首页 > 最新文献

Psychosomatics最新文献

英文 中文
书评
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.01.010
Nicholas Kontos M.D.
{"title":"","authors":"Nicholas Kontos M.D.","doi":"10.1016/j.psym.2020.01.010","DOIUrl":"10.1016/j.psym.2020.01.010","url":null,"abstract":"","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 869-870"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.01.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49441291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the Ask Suicide-Screening Questions for Adult Medical Inpatients: A Brief Tool for All Ages 对成年住院病人自杀筛查问题的验证:一个适用于所有年龄段的简短工具
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.04.008
Lisa M. Horowitz Ph.D., M.P.H. , Deborah J. Snyder M.S.W. , Edwin D. Boudreaux Ph.D. , Jian-Ping He M.S. , Colin J. Harrington M.D. , June Cai M.D. , Cynthia A. Claassen Ph.D. , Joan E. Salhany M.B.A.H.C.M., R.N. , Tram Dao Psy.D. , John F. Chaves M.D. , David A. Jobes Ph.D. , Kathleen R. Merikangas Ph.D. , Jeffrey A. Bridge Ph.D. , Maryland Pao M.D.

Background

Few brief suicide risk screening instruments are validated for use in both adult and pediatric medical populations. Using the pediatric Ask Suicide-Screening Questions (ASQ) development study as a model, this study aimed to determine whether the ASQ is a valid suicide risk–screening instrument for use among adults medical patients, as well as to evaluate a set of other potential screening questions for use in adults.

Methods

Adult patients hospitalized on inpatient medical/surgical units from 4 hospitals were recruited to participate in a cross-sectional instrument-validation study. The 4-item ASQ and other candidate items were compared against the 25-item, previously validated Adult Suicidal Ideation Questionnaire as the criterion standard.

Results

A total of 727 adult medical inpatients completed the screening process. Compared with the Adult Suicidal Ideation Questionnaire, the ASQ performed best among the full set of candidate items, demonstrating strong psychometric properties, with a sensitivity of 100% (95% confidence interval = 90%–100%), a specificity of 89% (95% confidence interval = 86%–91%), and a negative predictive value of 100% (95% confidence interval = 99%–100%). A total of 4.8% (35/727) of the participants screened positive for suicide risk based on the standard criterion Adult Suicidal Ideation Questionnaire.

Conclusions

The ASQ is a valid and brief suicide risk–screening tool for use among adults. Screening medical/surgical inpatients for suicide risk can be performed effectively for both adult and pediatric patients using this brief, primary screener.

背景:很少有简短的自杀风险筛查工具被证实适用于成人和儿科医疗人群。本研究以儿科自杀筛查问题(ASQ)发展研究为模型，旨在确定ASQ是否是一种有效的成人医疗患者自杀风险筛查工具，并评估一组其他可能用于成人的筛查问题。方法选取4所医院内科/外科住院的成年患者进行横断面仪器验证研究。将4项ASQ和其他候选项目与先前验证的25项成人自杀意念问卷作为判定标准进行比较。结果共有727名成年住院患者完成了筛查。与成人自杀意念问卷相比，ASQ在所有候选项目中表现最好，表现出较强的心理测量特性，灵敏度为100%(95%置信区间= 90% ~ 100%)，特异性为89%(95%置信区间= 86% ~ 91%)，负预测值为100%(95%置信区间= 99% ~ 100%)。在成人自杀意念量表中，有4.8%(35/727)的被试有自杀倾向。结论ASQ是一种有效、简便的成人自杀风险筛查工具。筛选医疗/外科住院病人的自杀风险可以有效地为成人和儿童患者使用这个简短的，初级筛选。
{"title":"Validation of the Ask Suicide-Screening Questions for Adult Medical Inpatients: A Brief Tool for All Ages","authors":"Lisa M. Horowitz Ph.D., M.P.H. ,&nbsp;Deborah J. Snyder M.S.W. ,&nbsp;Edwin D. Boudreaux Ph.D. ,&nbsp;Jian-Ping He M.S. ,&nbsp;Colin J. Harrington M.D. ,&nbsp;June Cai M.D. ,&nbsp;Cynthia A. Claassen Ph.D. ,&nbsp;Joan E. Salhany M.B.A.H.C.M., R.N. ,&nbsp;Tram Dao Psy.D. ,&nbsp;John F. Chaves M.D. ,&nbsp;David A. Jobes Ph.D. ,&nbsp;Kathleen R. Merikangas Ph.D. ,&nbsp;Jeffrey A. Bridge Ph.D. ,&nbsp;Maryland Pao M.D.","doi":"10.1016/j.psym.2020.04.008","DOIUrl":"10.1016/j.psym.2020.04.008","url":null,"abstract":"<div><h3>Background</h3><p>Few brief suicide risk screening instruments are validated for use in both adult and pediatric medical populations. Using the pediatric Ask Suicide-Screening Questions (ASQ) development study as a model, this study aimed to determine whether the ASQ is a valid suicide risk–screening instrument for use among adults medical patients, as well as to evaluate a set of other potential screening questions for use in adults.</p></div><div><h3>Methods</h3><p>Adult patients hospitalized on inpatient medical/surgical units from 4 hospitals were recruited to participate in a cross-sectional instrument-validation study. The 4-item ASQ and other candidate items were compared against the 25-item, previously validated Adult Suicidal Ideation Questionnaire as the criterion standard.</p></div><div><h3>Results</h3><p>A total of 727 adult medical inpatients completed the screening process. Compared with the Adult Suicidal Ideation Questionnaire, the ASQ performed best among the full set of candidate items, demonstrating strong psychometric properties, with a sensitivity of 100% (95% confidence interval = 90%–100%), a specificity of 89% (95% confidence interval = 86%–91%), and a negative predictive value of 100% (95% confidence interval = 99%–100%). A total of 4.8% (35/727) of the participants screened positive for suicide risk based on the standard criterion Adult Suicidal Ideation Questionnaire.</p></div><div><h3>Conclusions</h3><p>The ASQ is a valid and brief suicide risk–screening tool for use among adults. Screening medical/surgical inpatients for suicide risk can be performed effectively for both adult and pediatric patients using this brief, primary screener.</p></div>","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 713-722"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.04.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10786905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 55
Diagnostic Challenges and Treatment of the Neuropsychiatric Symptoms of Adult-Onset Niemann-Pick Type C With Electroconvulsive Therapy 电休克治疗成人型尼曼-匹克C型神经精神症状的诊断挑战和治疗
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.06.011
Rachel Foels B.S. , Kimberly Hartney M.D. , Alexis Cohen-Oram M.D.
{"title":"Diagnostic Challenges and Treatment of the Neuropsychiatric Symptoms of Adult-Onset Niemann-Pick Type C With Electroconvulsive Therapy","authors":"Rachel Foels B.S. ,&nbsp;Kimberly Hartney M.D. ,&nbsp;Alexis Cohen-Oram M.D.","doi":"10.1016/j.psym.2020.06.011","DOIUrl":"10.1016/j.psym.2020.06.011","url":null,"abstract":"","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 752-755"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.06.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38172987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Use of Security Dogs in De-escalation of Agitated Patients 安全犬在降低焦虑患者情绪升级中的应用
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.06.006
Janice Chung B.S. , Prudhvi Bandi B.S. , Daniel B. Janiczak M.D. , Jason P. Caplan M.D. , Curtis A. McKnight M.D.
{"title":"The Use of Security Dogs in De-escalation of Agitated Patients","authors":"Janice Chung B.S. ,&nbsp;Prudhvi Bandi B.S. ,&nbsp;Daniel B. Janiczak M.D. ,&nbsp;Jason P. Caplan M.D. ,&nbsp;Curtis A. McKnight M.D.","doi":"10.1016/j.psym.2020.06.006","DOIUrl":"10.1016/j.psym.2020.06.006","url":null,"abstract":"","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 756-758"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.06.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38155893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
End-Stage Anorexia Nervosa: When to Say “When”—A Literature Review of an Ethically Complicated Case 终末期神经性厌食症:何时说“何时”——一个伦理复杂案例的文献综述
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.05.011
Christine Sawhill D.O. , David C. Fipps D.O. , Jennifer V. Palomo M.S. , Melanie Miller M.D.
{"title":"End-Stage Anorexia Nervosa: When to Say “When”—A Literature Review of an Ethically Complicated Case","authors":"Christine Sawhill D.O. ,&nbsp;David C. Fipps D.O. ,&nbsp;Jennifer V. Palomo M.S. ,&nbsp;Melanie Miller M.D.","doi":"10.1016/j.psym.2020.05.011","DOIUrl":"10.1016/j.psym.2020.05.011","url":null,"abstract":"","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 779-786"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.05.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38160848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19 神经covid:与COVID-19相关的谵妄的药理学建议
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.05.013
Erica B. Baller M.D., M.S. , Charlotte S. Hogan M.D. , Mark A. Fusunyan M.D. , Ana Ivkovic M.D. , James W. Luccarelli M.D., D.Phil. , Elizabeth Madva M.D. , Mladen Nisavic M.D. , Nathan Praschan M.D., M.P.H. , Nadia V. Quijije M.D. , Scott R. Beach M.D. , Felicia A. Smith M.D.

Background

The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as one of the biggest health threats of our generation. A significant portion of patients are presenting with delirium and neuropsychiatric sequelae of the disease. Unique examination findings and responses to treatment have been identified.

Objective

In this article, we seek to provide pharmacologic and treatment recommendations specific to delirium in patients with COVID-19.

Methods

We performed a literature search reviewing the neuropsychiatric complications and treatments in prior coronavirus epidemics including Middle Eastern respiratory syndrome and severe acute respiratory syndrome coronaviruses, as well as the emerging literature regarding COVID-19. We also convened a work group of consultation-liaison psychiatrists actively managing patients with COVID-19 in our hospital. Finally, we synthesized these findings to provide preliminary pharmacologic recommendations for treating delirium in these patients.

Results

Delirium is frequently found in patients who test positive for COVID-19, even in the absence of respiratory symptoms. There appears to be a higher rate of agitation, myoclonus, abulia, and alogia. No data are currently available on the treatment of delirium in patients with COVID-19. Extrapolating from general delirium treatment, Middle Eastern respiratory syndrome/severe acute respiratory syndrome case reports, and our experience, preliminary recommendations for pharmacologic management have been assembled.

Conclusions

COVID-19 is associated with neuropsychiatric symptoms. Low-potency neuroleptics and alpha-2 adrenergic agents may be especially useful in this setting. Further research into the pathophysiology of COVID-19 will be key in developing more targeted treatment guidelines.

由严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2)引起的2019冠状病毒病(COVID-19)大流行已成为我们这一代人最大的健康威胁之一。很大一部分患者表现为谵妄和该疾病的神经精神后遗症。独特的检查结果和对治疗的反应已经确定。目的在本文中，我们寻求提供针对COVID-19患者谵妄的药物和治疗建议。方法查阅文献，回顾中东呼吸综合征和严重急性呼吸综合征冠状病毒等冠状病毒既往流行的神经精神并发症和治疗情况，以及新出现的有关COVID-19的文献。我们还召集了一个会诊联络精神科医生工作组，积极管理我院的COVID-19患者。最后，我们综合这些发现，为治疗这些患者的谵妄提供初步的药理学建议。结果谵妄常见于COVID-19检测阳性的患者，即使没有呼吸道症状。躁动、肌阵挛、食欲不振和痛症的发生率似乎更高。目前没有关于治疗COVID-19患者谵妄的数据。从一般谵妄治疗、中东呼吸综合征/严重急性呼吸综合征病例报告和我们的经验推断，已经收集了药物管理的初步建议。结论新型冠状病毒肺炎与神经精神症状相关。在这种情况下，低效抗精神病药和α -2肾上腺素能药物可能特别有用。进一步研究COVID-19的病理生理学将是制定更有针对性的治疗指南的关键。
{"title":"Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19","authors":"Erica B. Baller M.D., M.S. ,&nbsp;Charlotte S. Hogan M.D. ,&nbsp;Mark A. Fusunyan M.D. ,&nbsp;Ana Ivkovic M.D. ,&nbsp;James W. Luccarelli M.D., D.Phil. ,&nbsp;Elizabeth Madva M.D. ,&nbsp;Mladen Nisavic M.D. ,&nbsp;Nathan Praschan M.D., M.P.H. ,&nbsp;Nadia V. Quijije M.D. ,&nbsp;Scott R. Beach M.D. ,&nbsp;Felicia A. Smith M.D.","doi":"10.1016/j.psym.2020.05.013","DOIUrl":"10.1016/j.psym.2020.05.013","url":null,"abstract":"<div><h3>Background</h3><p>The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as one of the biggest health threats of our generation. A significant portion of patients are presenting with delirium and neuropsychiatric sequelae of the disease. Unique examination findings and responses to treatment have been identified.</p></div><div><h3>Objective</h3><p>In this article, we seek to provide pharmacologic and treatment recommendations specific to delirium in patients with COVID-19.</p></div><div><h3>Methods</h3><p>We performed a literature search reviewing the neuropsychiatric complications and treatments in prior coronavirus epidemics including Middle Eastern respiratory syndrome and severe acute respiratory syndrome coronaviruses, as well as the emerging literature regarding COVID-19. We also convened a work group of consultation-liaison psychiatrists actively managing patients with COVID-19 in our hospital. Finally, we synthesized these findings to provide preliminary pharmacologic recommendations for treating delirium in these patients.</p></div><div><h3>Results</h3><p>Delirium is frequently found in patients who test positive for COVID-19, even in the absence of respiratory symptoms. There appears to be a higher rate of agitation, myoclonus, abulia, and alogia. No data are currently available on the treatment of delirium in patients with COVID-19. Extrapolating from general delirium treatment, Middle Eastern respiratory syndrome/severe acute respiratory syndrome case reports, and our experience, preliminary recommendations for pharmacologic management have been assembled.</p></div><div><h3>Conclusions</h3><p>COVID-19 is associated with neuropsychiatric symptoms. Low-potency neuroleptics and alpha-2 adrenergic agents may be especially useful in this setting. Further research into the pathophysiology of COVID-19 will be key in developing more targeted treatment guidelines.</p></div>","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 585-596"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.05.013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38299579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 61
Physical Health and Psychosocial Considerations During the Coronavirus Disease 2019 Outbreak 2019冠状病毒病爆发期间的身体健康和心理社会考虑
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.07.005
Andrea Giacalone Ph.D., Gennaro Rocco Ph.D., Enzo Ruberti Ph.D.
{"title":"Physical Health and Psychosocial Considerations During the Coronavirus Disease 2019 Outbreak","authors":"Andrea Giacalone Ph.D.,&nbsp;Gennaro Rocco Ph.D.,&nbsp;Enzo Ruberti Ph.D.","doi":"10.1016/j.psym.2020.07.005","DOIUrl":"10.1016/j.psym.2020.07.005","url":null,"abstract":"","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 851-852"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.07.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38322743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
The Incapacitated Surrogate: What is the Consultation-Liaison Psychiatrist's Role? 无行为能力的代理:咨询联络精神科医生的角色是什么?
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.07.006
Nicole Allen M.D. , Adrienne Mishkin M.D., M.P.H.

Background

When a patient is found to be lacking capacity to make a medical decision, the medical team is advised to turn to the patient's most appropriate surrogate decision maker (hereafter, surrogate) to make a choice on behalf of the patient. The assumption made by the medical team is that the surrogate will have the capacity to make appropriate medical decisions on behalf of the patient. At times though, the capacity of the surrogate himself may be called into question, leading to uncertainty in terms of how best to proceed in the care of the patient. Consultation-liaison psychiatrists are commonly consulted to assess a patient's capacity to make a particular medical decision, but their role assisting in cases of incapacitated surrogates is less clear.

Objective

In this article, we summarize the existing literature and current state laws regarding incapacitated surrogates and propose guidelines for the role the consultation-liaison psychiatrist can take when the surrogate may be incapacitated.

背景:当发现患者缺乏做出医疗决定的能力时，建议医疗团队求助于患者最合适的代理决策者(以下简称“代理”)来代表患者做出选择。医疗团队的假设是，代孕母亲将有能力代表患者做出适当的医疗决定。但有时，代孕者自己的能力可能会受到质疑，导致如何最好地照顾病人的不确定性。咨询联络精神科医生通常被咨询以评估病人做出特定医疗决定的能力，但他们在无行为能力的代理人案件中的协助作用不太清楚。目的总结有关无行为能力代孕母亲的现有文献和国家现行法律，并就代孕母亲可能丧失行为能力时咨询联络精神科医生应发挥的作用提出指导意见。
{"title":"The Incapacitated Surrogate: What is the Consultation-Liaison Psychiatrist's Role?","authors":"Nicole Allen M.D. ,&nbsp;Adrienne Mishkin M.D., M.P.H.","doi":"10.1016/j.psym.2020.07.006","DOIUrl":"10.1016/j.psym.2020.07.006","url":null,"abstract":"<div><h3>Background</h3><p>When a patient is found to be lacking capacity to make a medical decision, the medical team is advised to turn to the patient's most appropriate surrogate decision maker (hereafter, surrogate) to make a choice on behalf of the patient. The assumption made by the medical team is that the surrogate will have the capacity to make appropriate medical decisions on behalf of the patient. At times though, the capacity of the surrogate himself may be called into question, leading to uncertainty in terms of how best to proceed in the care of the patient. Consultation-liaison psychiatrists are commonly consulted to assess a patient's capacity to make a particular medical decision, but their role assisting in cases of incapacitated surrogates is less clear.</p></div><div><h3>Objective</h3><p>In this article, we summarize the existing literature and current state laws regarding incapacitated surrogates and propose guidelines for the role the consultation-liaison psychiatrist can take when the surrogate may be incapacitated.</p></div>","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 672-677"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.07.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38375139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
CASPR2-IgG–Associated Autoimmune Encephalitis: Unusual Cause of Delirium caspr2 - igg相关的自身免疫性脑炎:谵妄的不寻常原因
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.05.017
Qi Sun M.D. , Tara Davidson M.D. , Jennifer Kleinman Sween M.D. , Christopher Klein M.D. , Thomas McLeod M.D. , Teresa Rummans M.D.
{"title":"CASPR2-IgG–Associated Autoimmune Encephalitis: Unusual Cause of Delirium","authors":"Qi Sun M.D. ,&nbsp;Tara Davidson M.D. ,&nbsp;Jennifer Kleinman Sween M.D. ,&nbsp;Christopher Klein M.D. ,&nbsp;Thomas McLeod M.D. ,&nbsp;Teresa Rummans M.D.","doi":"10.1016/j.psym.2020.05.017","DOIUrl":"10.1016/j.psym.2020.05.017","url":null,"abstract":"","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 774-778"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.05.017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38132154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Clonidine and Tizanidine for Management of Bipolar Disorder Due to Dengue Encephalopathy: A Case Report 可乐定和替扎尼定治疗登革脑病所致双相情感障碍1例
IF 3.4 Q2 Medicine
Psychosomatics
Pub Date : 2020-11-01 DOI: 10.1016/j.psym.2020.08.001
Pornjira Pariwatcharakul M.D., M.Sc., M.A., M.R.C.Psych. (UK), F.R.C.Psych.T., Maytinee Srifuengfung M.D., F.R.C.Psych.T.
{"title":"Clonidine and Tizanidine for Management of Bipolar Disorder Due to Dengue Encephalopathy: A Case Report","authors":"Pornjira Pariwatcharakul M.D., M.Sc., M.A., M.R.C.Psych. (UK), F.R.C.Psych.T.,&nbsp;Maytinee Srifuengfung M.D., F.R.C.Psych.T.","doi":"10.1016/j.psym.2020.08.001","DOIUrl":"10.1016/j.psym.2020.08.001","url":null,"abstract":"","PeriodicalId":20746,"journal":{"name":"Psychosomatics","volume":"61 6","pages":"Pages 727-731"},"PeriodicalIF":3.4,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.psym.2020.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38370471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Psychosomatics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1